Real-time enrollment status for this metastatic castration-resistant prostate cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 9:50 AM UTC
| NCT Number | NCT06492122 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Castration-resistant Prostate Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Full-Life Technologies UK Limited |
| Last Updated on CT.gov | May 26, 2026 (May 26, 2026) |
As of July 13, 2026: Clinical trial NCT06492122 is currently recruiting participants. This clinical trial study for metastatic castration-resistant prostate cancer is actively seeking new participants at 5 locations across the United States. The study is sponsored by Full-Life Technologies UK Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06492122 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06492122 was last updated May 26, 2026 (May 26, 2026). HelloStudys verifies this status automatically.